Weekly sirolimus for blood and lymph vessel malformations
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial studies whether taking sirolimus once a week can improve blood vessel, lymph vessel, or mixed (venolymphatic) malformations. It may help reduce symptoms and lesion size, while also monitoring safety in children and adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 2 years old
- You have a diagnosed blood, lymph, or mixed (venolymphatic) vessel malformation
- You (or your child’s legal guardian) must be able and willing to sign consent for the study
- You must not have had an organ transplant
- You must not have a known immune system problem or a problem caused on purpose (artificial immunodeficiency)
- You must not be taking medicines that block or strongly speed up how sirolimus is processed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of sirolimus (a medication that slows cell growth) to find the best dose for treating cystic lymphatic malformations in children. It may help shrink the abnormal fluid-filled growths and improve symptoms.
This trial tests a pill called everolimus to see if it can shrink or control abnormal blood vessel growths (vascular anomalies) that have not responded to other treatments. It may offer a new option for patients aged 1 year and older.
This trial studies whether sirolimus (Rapamune®) can reduce problems from severe arteriovenous malformations (tangled blood vessel connections). It may help shrink the abnormal vessels or improve symptoms, by testing the medicine in people with certain AVM types.
This Phase 3 study tests whether sirolimus helps control complex vascular anomalies that have not responded to standard treatments. It also checks safety by monitoring blood tests, organ function, and overall health during treatment.
This trial tests if sirolimus can help children with a certain type of eye socket malformation. It aims to find a better treatment for children aged 1 to 18.
This trial tests whether sirolimus, a medication usually used to prevent organ transplant rejection, can help reduce lupus disease activity. If you have active lupus that isn't severe in your kidneys or brain, this could be a new treatment option.
Hear when a new Venous Malformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.